237 related articles for article (PubMed ID: 3030529)
1. Axillary lymph node dissection for intraductal breast carcinoma--is it indicated?
Silverstein MJ; Rosser RJ; Gierson ED; Waisman JR; Gamagami P; Hoffman RS; Fingerhut AG; Lewinsky BS; Colburn W; Handel N
Cancer; 1987 May; 59(10):1819-24. PubMed ID: 3030529
[TBL] [Abstract][Full Text] [Related]
2. Axillary lymphadenectomy for intraductal carcinoma of the breast.
Silverstein MJ; Gierson ED; Colburn WJ; Rosser RJ; Waisman JR; Gamagami P
Surg Gynecol Obstet; 1991 Mar; 172(3):211-4. PubMed ID: 1847243
[TBL] [Abstract][Full Text] [Related]
3. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy.
Zafrani B; Fourquet A; Vilcoq JR; Legal M; Calle R
Cancer; 1986 Apr; 57(7):1299-301. PubMed ID: 3004688
[TBL] [Abstract][Full Text] [Related]
4. [10 years' experience with the concept of breast-saving therapy in the treatment of breast cancer].
Staffen A; Stadler B; Strasser K; Schreiner W; Wolner E
Chirurg; 1985 Jul; 56(7):436-9. PubMed ID: 2994965
[TBL] [Abstract][Full Text] [Related]
5. Ten year results of conservative surgery and irradiation for stage I and II breast cancer.
Fowble BL; Solin LJ; Schultz DJ; Goodman RL
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):269-77. PubMed ID: 1648040
[TBL] [Abstract][Full Text] [Related]
6. The incidence and predictor of lymph node metastasis for patients with T1mi breast cancer who underwent axillary dissection and breast irradiation: an institutional analysis.
Lee JH; Suh YJ; Shim BY; Kim SH
Jpn J Clin Oncol; 2011 Oct; 41(10):1162-7. PubMed ID: 21903706
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
8. Extent of axillary dissection preceding irradiation for carcinoma of the breast.
Schwartz GF; D'Ugo DM; Rosenberg AL
Arch Surg; 1986 Dec; 121(12):1395-8. PubMed ID: 3024603
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative implantation radiation therapy plus lumpectomy for carcinoma of the breast.
Jewell WR; Krishnan L; Reddy EK; Thomas JH; Mansfield CM
Arch Surg; 1987 Jun; 122(6):687-90. PubMed ID: 3034194
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.
Wasserberg N; Morgenstern S; Schachter J; Fenig E; Lelcuk S; Gutman H
Arch Surg; 2002 Nov; 137(11):1249-52. PubMed ID: 12413311
[TBL] [Abstract][Full Text] [Related]
11. [Influence of the number of removed axillary lymph nodes on the prognosis of node-negative primary breast cancer].
Wang HY; Dong HT; Liu Q; Xing P; Li JG
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):457-60. PubMed ID: 22967449
[TBL] [Abstract][Full Text] [Related]
12. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer.
Fowble B; Solin LJ; Schultz DJ; Goodman RL
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):703-10. PubMed ID: 2550398
[TBL] [Abstract][Full Text] [Related]
13. Wide excision of the tumor, axillary dissection, and postoperative radiotherapy as treatment of small breast cancers.
Durand JC; Poljicak M; Lefranc JP; Pilleron JP
Cancer; 1984 Jun; 53(11):2439-43. PubMed ID: 6324984
[TBL] [Abstract][Full Text] [Related]
14. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer.
Wong JH; Kopald KH; Morton DL
Arch Surg; 1990 Oct; 125(10):1298-301; discussion 1301-2. PubMed ID: 2171453
[TBL] [Abstract][Full Text] [Related]
15. Duct carcinoma in situ: 227 cases without microinvasion.
Silverstein MJ; Cohlan BF; Gierson ED; Furmanski M; Gamagami P; Colburn WJ; Lewinsky BS; Waisman JR
Eur J Cancer; 1992; 28(2-3):630-4. PubMed ID: 1317201
[TBL] [Abstract][Full Text] [Related]
16. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
[TBL] [Abstract][Full Text] [Related]
17. Axillary recurrence in DCIs: is axillary lymphadenectomy warranted?
Trisal V; Qian D; Wagman LD
Am Surg; 2004 Oct; 70(10):876-80. PubMed ID: 15529841
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
[TBL] [Abstract][Full Text] [Related]
19. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
20. [Axillary recurrences after sentinel lymph node biopsy in initial breast cancer].
Sampol C; Giménez M; Torrecabota J; Serra C; Canet R; Daumal J; Peña C; Gonzalez L; Hernandez E; Graner A; Pozo A; Vega F
Rev Esp Med Nucl; 2010; 29(5):241-5. PubMed ID: 20466461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
